While low-rely MBL almost never progresses to CLL, large-rely MBL progresses to CLL demanding therapy at a level of 1% to two% a year. Superior-rely MBL is distinguished from Rai 0 CLL depending on if the B-mobile rely is higher than or below 5 × 109/L. Though men and women with both of those